跳至主要内容
临床试验/ITMCTR2100004443
ITMCTR2100004443招募中未知

The prospective study on differentiation and treatment of membranous nephropathy by Wenyang Huaji method

Beijing Hospital of TCM0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1.Conforms to the MN diagnostic criteria.
  • 2.Conforms to the diagnostic criteria of Shaoyin Taiyin syndrome.
  • 3.The patient has signed the informed consent.
  • 4.Between the ages of 18 and 75.
  • 5.CKD stage I-III, eGFR > 30ml/min, serum albumin > 15g/L.

排除标准

  • 1. Progressive membranous nephropathy (progressive decrease of renal function;Kidney biopsy showed necrotizing capillaritis and > 50% large crescent), accompanied by IgA nephropathy, diabetic nephropathy and other kidney diseases.
  • 2. Confirmed by hepatitis B, systemic lupus erythematosus, tumor, drug damage and other factors secondary and need to actively treat the primary disease, such as active hepatitis B and persistent liver function test transaminase abnormalities, or anti-nuclear antibodies, double Abnormal strand DNA, ANCA or other indicators of immune disease.
  • 3. With acute central nervous system disease, severe gastrointestinal disease, a history of HIV infection, a history of mental illness or a history of malignancy.
  • 4. With other organ diseases and dysfunction, and with life-threatening complications such as severely infected persons.
  • 5. Pregnant or lactating women.
  • 6. Other clinical trials are under study.

研究者

发起方
Beijing Hospital of TCM

相似试验